Table 4.
Antibiotic resistance phenotypic patterns of EAEC isolates
| Resistance pattern | Phenotypic resistance | Number of resistant EAEC isolates (%) |
|---|---|---|
| I | AMP-SXT | 1 (3.1%) |
| II | AMP-TET-SXT | 2 (6.2%) |
| III | AMP-TET-SXT-AZM | 1 (3.1%) |
| IV | GEN-CTX-CPDX-AMP-CRO-SXT-AZM | 1 (3.1%) |
| V | GEN-CTX-CPDX-AMP-TET-SXT-AZM | 1 (3.1%) |
| VI | GEN-AN-CIP-AMP-CRO-SXT-AZM | 1 (3.1%) |
| VII | GEN-CAZ-CTX-CPDX-AMP-CRO-SXT-AZM | 3 (9.3%) |
| VIII | GEN-CIP-CAZ-CTX-CPDX-AMP-CRO-SXT-AZM | 1 (3.1%) |
| IX | GEN-FOX-CAZ-CTX-CPDX-AMP-CRO-TET-SXT-AZM | 1 (3.1%) |
| X | GEN-FOX-CAZ-CTX-CPDX-MEM-AMP-CRO-TET-SXT-AZM | 2 (6.2%) |
| XI | CTX-CPDX-AMP-CRO-SXT | 1 (3.1%) |
| XII | CTX-CPDX-AMP-CRO-SXT-AZM | 4 (12.5%) |
| XIII | CTX-CPDX-AMP-CRO-TET-SXT-AZM | 2 (6.2%) |
| XIV | AN-AMP-TET-SXT-AZM | 1 (3.1%) |
| XV | AN-CAZ-CTX-CPDX-MEM-AMP-CRO-SXT | 1 (3.1%) |
| XVI | AN-CAZ-CTX-CPDX-AMP-CRO-SXT-AZM | 1 (3.1%) |
| XVII | CIP-CAZ-CTX-CPDX-AMP-CRO-SXT-AZM | 3 (9.3%) |
| XVIII | CIP-FOX-CAZ-CTX-CPDX-AMP-CRO-TET-SXT-AZM | 1 (3.1%) |
| XIX | CAZ-CTX-CPDX-AMP-CRO-TET-SXT | 2 (6.2%) |
| XX | CAZ-CTX-CPDX-AMP-CRO-TET-SXT-AZM | 1 (3.1%) |
| XXI | FOX-CAZ-CTX-CPDX-AMP-CRO-TET-SXT-AZM | 1 (3.1%) |
Abbreviations: EAEC, enteroaggregative Escherichia coli; AMP, ampicillin; AN, amikacin; AZM, azithromycin; CTX, cefotaxime; CRO, ceftriaxone; CAZ, ceftazidime; CPDX, cefpodoxime; CIP, ciprofloxacin; FOX, cefoxitin; GEN, gentamicin; MEM, meropenem; SXT, trimethoprimsulfamethoxazole; TET, tetracycline.